Abstract
The recent Hot Topics section focuses on survival rates for patients with cholangiocarcinoma.
MeSH terms
-
Bile Duct Neoplasms* / drug therapy
-
Bile Duct Neoplasms* / pathology
-
Bile Duct Neoplasms* / therapy
-
Cholangiocarcinoma* / drug therapy
-
Cholangiocarcinoma* / mortality
-
Cholangiocarcinoma* / pathology
-
Cholangiocarcinoma* / therapy
-
Humans
-
Neoadjuvant Therapy* / methods
-
Survival Rate